Latest News

Adderall shortage reported by pharmacies, patients


 

Adderall, the attention-deficit/hyperactivity disorder medication, is in short supply in some parts of the nation, pharmacy chains and Adderall users say.

Half a dozen people told Bloomberg that pharmacies told them in August and September that the drug was out of stock. The patients were told the drug might not be available for weeks, though it’s supposed to be taken daily. BuzzFeed News said 20 people across the nation said that their pharmacies didn’t have Adderall in stock.

“It’s so frustrating that getting my meds requires me to be organized, focused, and motivated – all the things I’m on these meds to help with,” Irene Kelly, who has been using Adderall for 14 years, told BuzzFeed News.

Two pharmacy chains told Bloomberg that Adderall has not always been available to sell. Walgreens spokesperson Rebekah Pajak said there were “supply chain challenges” affecting instant-release and extended-release versions of the drug. CVS pharmacies can fill Adderall prescriptions “in most cases,” CVS spokesperson Matthew Blanchette said.

Several drugmakers have had brand-name and generic versions of Adderall on back order for months, Bloomberg reported. The problem started with a labor shortage at Teva Pharmaceutical, the top seller of Adderall in the United States, that created a limited supply of brand-name and generic instant-release Adderall, according to the outlet.

That said, the Food and Drug Administration is not reporting an Adderall shortage on its drug shortages database. The federal agency says it lists a drug as being in short supply when “overall market demand is not being met by the manufacturers of the product,” Bloomberg said.

“Manufacturers continue to release product,” FDA spokesperson Cherie Duvall-Jones said, according to Bloomberg.

Demand for Adderall is growing, possibly because of rising ADHD diagnoses that occurred during telehealth medical appointments amid the COVID-19 pandemic, Bloomberg reported, noting that some of those telehealth companies have come under scrutiny by the Drug Enforcement Administration and other government agencies.

NBC News, citing IQVIA, an analytics provider for the life sciences industry, reported that 41.4 million Adderall prescriptions were issued last year, up 10.4% from 2020.

A version of this article first appeared on WebMD.com.

Recommended Reading

New obesity target? Dopamine circuit in brainstem affects satiety
MDedge Internal Medicine
Stimulant reduces ‘sluggish cognitive tempo’ in adults with ADHD
MDedge Internal Medicine
ADHD med may reduce apathy in Alzheimer’s disease
MDedge Internal Medicine
Cannabis use: Messages remain mixed across diagnoses
MDedge Internal Medicine
City or country life? Genetic risk for mental illness may decide
MDedge Internal Medicine
Is prescribing stimulants OK for comorbid opioid use disorder, ADHD?
MDedge Internal Medicine
New AAD guidelines eye comorbidities in adults with atopic dermatitis
MDedge Internal Medicine
Four mental health trajectories in youth: Predicting persistent psychopathology
MDedge Internal Medicine
Multiple mental health woes? Blame it on genetics
MDedge Internal Medicine
Skin-picking, hair-pulling disorders: Diagnostic criteria, prevalence, and treatment
MDedge Internal Medicine